NRC Health (NRC) Q2 FY26 earnings call

NRC Health delivered strong Q2 FY26 results, marked by double-digit TRCV growth and strategic product innovation, particularly with the launch of ambient listening with agentic AI. The company is investing in delivery and product development to support recent large wins and future opportunities, expecting margin expansion in the second half of the year as revenue catches up to TRCV growth. Management remains confident in its differentiated position despite competitive market shifts.